4//SEC Filing
Ashar Bhavesh 4
Accession 0001104659-24-002371
CIK 0001773427other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 9:06 PM ET
Size
11.0 KB
Accession
0001104659-24-002371
Insider Transaction Report
Form 4
Ashar Bhavesh
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-04+75,000→ 75,000 totalExercise: $38.40Exp: 2034-01-03→ Common Stock (75,000 underlying) - Tax Payment
Common Stock
2024-01-05$37.96/sh−2,507$95,166→ 67,659 total - Tax Payment
Common Stock
2024-01-08$41.53/sh−1,449$60,177→ 66,210 total - Award
Common Stock
2024-01-04+26,445→ 70,166 total
Footnotes (3)
- [F1]This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty-three percent (33%) to vest on January 4, 2025, another thirty-three percent (33%) to vest on January 4, 2026 and the remaining thirty-four percent (34%) to vest on January 4, 2027, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs and does not represent a sale by the Reporting Person.
- [F3]This option shall vest in forty-eight (48) equal monthly installments following January 4, 2024, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.
Documents
Issuer
SpringWorks Therapeutics, Inc.
CIK 0001773427
Entity typeother
Related Parties
1- filerCIK 0001849740
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 9:06 PM ET
- Size
- 11.0 KB